Related Experiment Videos
Vitamin A intoxication during taxol therapy for refractory ovarian cancer
Journal of the National Cancer Institute
|September 16, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase 2 feasibility study of nab-paclitaxel and carboplatin in epithelial carcinoma of the uterus.
Gynecologic oncology·2024
BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2005
Platinums: extending their therapeutic spectrum.
Journal of chemotherapy (Florence, Italy)·2005
Sequential single agents as first-line chemotherapy for ovarian cancer: a strategy derived from the results of GOG-132.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2003
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions.
Annals of oncology : official journal of the European Society for Medical Oncology·2003
Expansion of the world health organization (WHO) gastric neuroendocrine tumor classification: introducing types 4 and 5.
Journal of the National Cancer Institute·2026
Opioid limiting law and opioid prescriptions among Medicaid-enrolled survivors of childhood cancer.
Journal of the National Cancer Institute·2026
Ancestry-Dependent Immunologic and Prognostic Effects Characterize the Prostate Cancer Urinary Proteome.
Journal of the National Cancer Institute·2026
SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis.
Journal of the National Cancer Institute·2026
PRO‑CTCAE in Oncology Drug Evaluation: Cross-Agency Review of Regulatory and Health Technology Assessment Decision-Making in the United States and Europe.
Journal of the National Cancer Institute·2026
Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention.
Journal of the National Cancer Institute·2026